Biovax Campy

Kraj: Nowa Zelandia

Język: angielski

Źródło: Ministry for Primary Industries

Składnik aktywny:

campylobacter jejuni (inactivated); campylobacter fetus subsp fetus (inactivated)

Dostępny od:

New Zealand Biovax

INN (International Nazwa):

campylobacter fetus subsp fetus (inactivated), campylobacter jejuni (inactivated)

Skład:

campylobacter jejuni (inactivated) 0 vaccine; campylobacter fetus subsp fetus (inactivated) 0 vaccine

Dziedzina terapeutyczna:

Vaccine

Status autoryzacji:

ACVM Registered

Data autoryzacji:

2015-12-09

Charakterystyka produktu

BIOVAXCAMPY PRIMARY BOTTLE - FRONT
OCT 2018
Keep out of reach of children
100mL/250mL/500mL
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
BIOVAXCAMPY
TM
Prevents abortion and perinatal loss caused by _Campylobacter fetus
_or _Campylobacter jejuni_
DIRECTIONS FOR USE: Read entire label prior to use.
DOSE Sheep = 2mL subcutaneously in the anterior (front) half of the
neck
Contains inactivated _Campylobacter fetus_ subspecies _fetus_, and
_Campylobacter jejuni._
ACVM No. A11046
Batch & Expiry
BIOVAXCAMPY PRIMARY BOTTLE -FOLD OUT
NOV 2015
HANDLING PRECAUTION WARNING may cause an allergic skin reaction. Avoid
skin
contact
FIRST AID. If on skin, wash with plenty of soap and water. If skin
irritation/rash occurs seek
medical advice. For advice contact the National Poisons Centre 0800
POISON (0800 764
766) or a doctor.
ACCIDENTAL SELF-INJECTION - Obtain medical attention - show this
leaflet and/or SDS
Accidental self-injection may lead to an inflammatory response and
medical advice should be
sought on the management of deep injections, particularly those near a
joint or associated
with bruising. If possible the application of gentle squeezing
pressure with absorbent material
(e.g. facial tissues) at the injection site will swab up unabsorbed
vaccine. Strong squeezing of
the site should be avoided. The damaged area should be thoroughly
cleansed and a topical
antiseptic applied.
ADVICE TO DOCTOR - Treat symptomatically. Minor surgical debridement
and antibiotics
may be necessary. Some risk of hypersensitivity from injection.
Contamination of the needle must be considered.
DISPOSAL Dispose of contents and empty pack by burying in an approved
landfill.
See Safety Data Sheet for further information.
BIOVAXCAMPY PRIMARY BOTTLE -FOLD OUT
NOV 2015
VACCINATION PROGRAMME:
Sensitiser
Booster
First year
Inject prior to mating
Inject approximately 3-12
weeks later
Subsequent years
Not required
Inject prior to mating
Whole flock vaccination is recommended.
As with all vaccines, efficacy is based on the immune response of
an